SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
__________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): March 27, 2008
|
THE
FEMALE HEALTH
COMPANY
|
|
(Exact
name of registrant as specified in its
charter)
|
|
Wisconsin
|
|
(State
or other jurisdiction of
incorporation)
|
|
1-13602
|
|
39-1144397
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer I.D. Number)
|
|
515
North State Street
Suite
2225
Chicago,
Illinois
|
|
60610
|
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
|
312-595-9123
|
|
(Registrant's
telephone number, including area code)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act
(17
CFR230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR
240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Section
5 – Corporate Governance and Management
Item
5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers
On
March 27, 2008, at the annual
meeting of shareholders of The Female Health Company (the "Company"),
shareholders approved a proposal to adopt The Female Health Company 2008
Stock
Incentive Plan (the "Stock Incentive Plan"). A copy of the Stock
Incentive Plan is attached hereto as an exhibit and is incorporated herein
by
reference.
A
summary description of the terms of
the Stock Incentive Plan is set forth in the Company's definitive proxy
statement on Schedule 14A filed with the Securities and Exchange Commission
on February 20, 2008. The section of the definitive proxy
statement entitled "Approval of 2008 Stock Incentive Plan" from pages 16
to 18
is incorporated herein by reference.
Section
9 – Financial Statements and Exhibits
Item
9.01 Financial Statements and Exhibits
(d) Exhibits
The following exhibit is filed herewith:
Exhibit 99.1
– The Female Health Company 2008 Stock Incentive Plan.
SIGNATURES
Pursuant
to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report
to
be signed on its behalf by the undersigned hereunto duly authorized.
THE
FEMALE HEALTH COMPANY
Date: March 31,
2008
BY
/s/
Donna Felch
Donna
Felch, Vice President and
Chief
Financial Officer